Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08OQQ
|
||||
Former ID |
DIB000512
|
||||
Drug Name |
Lavoltidine
|
||||
Synonyms |
Loxtidine; AH-234844; GSK-1023911a; GSK-1040323b; Histamine H2 receptor antagonist (GERD), GlaxoSmithKline; Histamine H2 receptor antagonist (gastroesophageal reflux disorder), GlaxoSmithKline
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Gastroesophageal reflux disease [ICD9: 140-229, 530; ICD10:K21] | Discontinued in Phase 2 | [544542] | ||
Company |
GlaxoSmithKline plc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H29N5O2
|
||||
Canonical SMILES |
c1(cc(ccc1)OCCCNc1nc(nn1C)CO)CN1CCCCC1
|
||||
CAS Number |
CAS 76956-02-0
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Histamine H2 receptor | Target Info | Antagonist | [544366] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.